JD
Jal Devi
About Jal Devi
Data last updated:
Jal Devi is a Director at Sjaldine Pharmaceuticals Private Limited (since 2017) and Director at Shayla Health Private Limited (since 2019). The companies operate in Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹64.4 Lakh; the largest is Sjaldine Pharmaceuticals Private Limited at ₹47.9 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sjaldine Pharmaceuticals Private Limited U24299UP2017PTC098435 | Director | 08 Nov 2017 | 2017 | ₹47.9 Lakh (FY 2024) | Active |
| Shayla Health Private Limited U24100UP2019PTC112756 | Director | 24 Jan 2019 | 2019 | ₹16.5 Lakh (FY 2024) | Active |
Board colleagues of Jal Devi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Monica Narayan | 10078709 | Sjaldine Pharmaceuticals Private Limited , Shayla Health Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jal Devi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jal Devi
Jal Devi currently holds 2 directorships: Sjaldine Pharmaceuticals Private Limited (Director, since 08 Nov 2017, revenue ₹47.9 Lakh (FY 2024)); Shayla Health Private Limited (Director, since 24 Jan 2019, revenue ₹16.5 Lakh (FY 2024)).
Jal Devi was first appointed on 08 Nov 2017 as Director at Sjaldine Pharmaceuticals Private Limited. The most recent appointment on record is 24 Jan 2019 at Shayla Health Private Limited.
The 2 current companies of Jal Devi that report revenue have a combined latest revenue of ₹64.4 Lakh: Sjaldine Pharmaceuticals Private Limited ₹47.9 Lakh (FY 2024); Shayla Health Private Limited ₹16.5 Lakh (FY 2024).
The current boards of Jal Devi's companies include Monica Narayan (Sjaldine Pharmaceuticals Private Limited).